Prevalence and impact of diabetes among people infected with SARS-CoV-2

J Endocrinol Invest. 2020 Jun;43(6):867-869. doi: 10.1007/s40618-020-01236-2. Epub 2020 Mar 28.

Authors

G P Fadini¹, M L Morieri², E Longato³, A Avogaro²

Affiliations

¹ Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. gianpaolo.fadini@unipd.it.
² Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.
³ Department of Information Engineering, University of Padova, Padua, Italy.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Betacoronavirus / isolation & purification
COVID-19
China / epidemiology
Coronavirus Infections / epidemiology*
Coronavirus Infections / physiopathology
Coronavirus Infections / virology
Diabetes Mellitus / epidemiology*
Diabetes Mellitus / physiopathology
Diabetes Mellitus / virology
Female
Humans
Italy / epidemiology
Male
Middle Aged
Pandemics
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / physiopathology
Pneumonia, Viral / virology
Prevalence
SARS-CoV-2